Gyre Therapeutics (GYRE) Cash from Investing Activities Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -255.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -255.31% |
| Dec 31, 2025 | 192.22% |
| Sep 30, 2025 | 47.76% |
| Jun 30, 2025 | 63.23% |
| Mar 31, 2025 | 127.24% |
| Dec 31, 2024 | -249.66% |
| Sep 30, 2024 | 55.80% |
| Jun 30, 2024 | -2.76% |
| Mar 31, 2024 | 5.60% |
| Dec 31, 2023 | 101.94% |
| Jun 30, 2023 | -115.23% |
| Mar 31, 2023 | -405.43% |
| Dec 31, 2022 | -2,514.13% |
| Jun 30, 2022 | 393.94% |
| Mar 31, 2022 | -90.92% |
| Dec 31, 2021 | -89.60% |
| Sep 30, 2021 | 133.09% |
| Jun 30, 2021 | 144.52% |
| Mar 31, 2021 | 0.58% |
| Dec 31, 2020 | 6,161.59% |
| Sep 30, 2020 | -245.39% |
| Jun 30, 2020 | -756.71% |
| Mar 31, 2020 | 216.53% |
| Dec 31, 2019 | -89.41% |
| Sep 30, 2019 | 502.09% |
| Jun 30, 2019 | 105.04% |
| Mar 31, 2019 | 978.83% |
| Dec 31, 2018 | 373.72% |
| Sep 30, 2018 | 77.92% |
| Jun 30, 2018 | -7,264,000.00% |
| Mar 31, 2018 | -88.19% |
| Dec 31, 2017 | -125.99% |
| Sep 30, 2017 | -791.31% |
| Jun 30, 2017 | 99.98% |
| Mar 31, 2017 | 280.22% |
| Dec 31, 2016 | -46.78% |
| Sep 30, 2016 | -90.99% |
| Jun 30, 2016 | -1,971.94% |
| Mar 31, 2016 | -1,806.79% |
| Sep 30, 2015 | 383.65% |
| Jun 30, 2015 | -103.71% |
| Mar 31, 2015 | -88.58% |
| Sep 30, 2014 | -209.03% |
| Jun 30, 2014 | 98.15% |
| Mar 31, 2014 | 167.82% |
| Dec 31, 2013 | -160.09% |
| Sep 30, 2013 | -48.92% |
| Jun 30, 2013 | 721.09% |
| Mar 31, 2013 | -142.01% |
| Dec 31, 2012 | 822.68% |
| Sep 30, 2012 | 188.09% |
| Jun 30, 2012 | 101.49% |
| Mar 31, 2012 | 222.62% |
| Dec 31, 2011 | 64.87% |
| Sep 30, 2011 | 5.20% |